Trulieve Cannabis Corp. (NYSE:TRLV – Get Free Report) CEO Kim Rivers sold 137,535 shares of the business’s stock in a transaction that occurred on Wednesday, June 17th. The shares were sold at an average price of $9.36, for a total transaction of $1,287,327.60. Following the completion of the transaction, the chief executive officer owned 3,038,385 shares of the company’s stock, valued at $28,439,283.60. The trade was a 4.33% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.
Trulieve Cannabis Stock Down 8.9%
NYSE:TRLV traded down $0.90 during trading hours on Monday, hitting $9.21. The company’s stock had a trading volume of 4,066,680 shares, compared to its average volume of 510,400. Trulieve Cannabis Corp. has a twelve month low of $3.25 and a twelve month high of $13.28.
Wall Street Analysts Forecast Growth
Separately, Weiss Ratings started coverage on Trulieve Cannabis in a research note on Tuesday, June 16th. They issued a “sell (d-)” rating on the stock. One research analyst has rated the stock with a Sell rating, Based on data from MarketBeat, the company presently has a consensus rating of “Sell”.
Trulieve Cannabis Company Profile
Trulieve Cannabis Corp. is a vertically integrated cannabis company focused on the cultivation, processing, and retail sale of medical and adult-use cannabis products. The company offers a range of products that may include flower, pre-rolls, concentrates, edibles, vape products, and topicals through its dispensary network and branded product portfolio.
Trulieve’s operations have been centered primarily in the United States, with a strong presence in Florida and additional markets in other states where cannabis is legally regulated.
See Also
- Five stocks we like better than Trulieve Cannabis
- Buy CrowdStrike Before the Stock Split? Here’s the Case
- Investors Are Buying Into Sweetgreen Again—Should They?
- Burlington Is Winning Over Shoppers But Investors Need Patience
- USA Today’s Digital Revival Is Gaining Steam, But With Plenty of Risk
Receive News & Ratings for Trulieve Cannabis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Trulieve Cannabis and related companies with MarketBeat.com's FREE daily email newsletter.
